the southwest oncology group in a prospective randomized study compared one year of adjuvant combination chemotherapy with continuous cmfvp ( cyclophosphamide , methotrexate , 5-fluorouracil , vincristine , and prednisone ) to two years of intermittent l-phenylalanine mustard ( l-pam ) in women with operable breast cancer with histologically positive axillary lymph nodes .
C0055987
cmfvp
C0025677
methotrexate